Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Survival”

115 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 115 results

Not applicableUnknownNCT01860508
What this trial is testing

PC Sequential Pemetrexed Single Drug Maintenance Treatment for NSCLC and Related Predictive Biomarkers

Who this might be right for
Non-small Cell Lung Cancer
Fudan University 94
Not applicableStudy completedNCT02091011
What this trial is testing

LONGEVITY Study. Evaluation of the Device and Battery Longevity of Boston Scientific Market-released ICD and CRT-D Devices

Who this might be right for
Implantable Cardioverter DefibrillatorsCRT-D Cardiac Resynchronization Therapy Defibrillator
Boston Scientific Corporation 1,600
Not applicableStudy completedNCT02109549
What this trial is testing

Influence of the Use of the Diabetic Drug Metformin on the Overall Survival and Treatment-related Toxicity in Advanced Stage Non-small Cell Lung Cancer Patients.

Who this might be right for
Non Small Cell Lung Cancer
Maastricht Radiation Oncology 70
Not applicableLooking for participantsNCT06595147
What this trial is testing

Breast cancEr, FITness and ExeRcise for Heart Health: The BE-FITTER Study

Who this might be right for
Breast CancerDisability PhysicalHeart Failure+1 more
University of Alberta 60
Large-scale testing (Phase 3)Looking for participantsNCT06419946
What this trial is testing

Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

Who this might be right for
Glioblastoma, IDH-wildtypeMGMT-Methylated Glioblastoma
Vastra Gotaland Region 200
Not applicableActive Not RecruitingNCT02936505
What this trial is testing

Clinical Study Evaluating Two Treatment Protocols for Immunosuppressive Drugs. Looking at 3-year Incidence of CLAD.

Who this might be right for
Lung TransplantationAllografts
Vastra Gotaland Region 249
Not applicableActive Not RecruitingNCT07233759
What this trial is testing

The Study Collect Clinical Data From the Treatment of Liver Cancer With New Drugs After 2019 and Integrate Biochemical and Pathological Indicators to Analyze Prognostic Outcomes, Including Overall Survival, Progression-free Survival, and Complications.

Who this might be right for
Liver CancerPembrolizumabAtezolizumab+1 more
National Taiwan University Hospital 2,500
Large-scale testing (Phase 3)Enrolling By InvitationNCT06950190
What this trial is testing

Evaluating Cognitive Changes on Patients in Chemotherapy (ECCPC)

Who this might be right for
Chemotherapy-related Cognitive Impairment
Ellis Medicine 100
Testing effectiveness (Phase 2)Study completedNCT00109005
What this trial is testing

Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma

Who this might be right for
Melanoma
National Cancer Institute (NCI) 17
Large-scale testing (Phase 3)Study completedNCT00775307
What this trial is testing

Adjuvant Pazopanib in Stage I NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Intergroupe Francophone de Cancerologie Thoracique 142
Not applicableLooking for participantsNCT06329531
What this trial is testing

Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic

Who this might be right for
CancerOccupational Therapy
M.D. Anderson Cancer Center 80
Not applicableStudy completedNCT05036408
What this trial is testing

Cancer Pain Rehabilitation Program to Reduce Pain Related Distress, and Reliance of Pain Medication Through Multimodal Nonpharmacological Solutions

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
City of Hope Medical Center 16
Testing effectiveness (Phase 2)Study completedNCT00068458
What this trial is testing

Survival TRaining for ENhancing Total Health (STRENGTH)

Who this might be right for
Breast CancerDepressionWeight Changes
Duke University 39
Post-approval studies (Phase 4)Study completedNCT00966615
What this trial is testing

The Effect of Neutral Peritoneal Dialysis (PD) Solution With Minimal Glucose-Degradation-Product (GDP) on Fluid Status and Body Composition

Who this might be right for
Renal FailureESRDCardiovascular Disease
Chinese University of Hong Kong 68
Testing effectiveness (Phase 2)UnknownNCT04351308
What this trial is testing

Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma

Who this might be right for
OsteosarcomaSurvivalChemotherapy Effect+1 more
Peking University People's Hospital 60
Large-scale testing (Phase 3)Study completedNCT01259414
What this trial is testing

Comparison of Two Solvents Used With Chemotherapy Agent for Transarterial Chemoembolization of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 812
Post-approval studies (Phase 4)UnknownNCT05229809
What this trial is testing

Clinical Trial of Yiqi Wenyang Jiedu Prescription in the Prevention and Treatment of Postoperative Metastasis and Recurrence of Gastric Cancer

Who this might be right for
Gastric Carcinoma
Jie Li 212
Not applicableStudy completedNCT01934465
What this trial is testing

Bevacizumab Plus Chemotherapy for Advanced Non Small Cell Lung Cancer Patients as 1st Line Treatment

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 300
Early research (Phase 1)UnknownNCT01624077
What this trial is testing

Safety Study of Using Regulatory T Cells Induce Liver Transplantation Tolerance

Who this might be right for
Chronic Rejection of Liver Transplant
Nanjing Medical University 1
Testing effectiveness (Phase 2)Study completedNCT00239980
What this trial is testing

Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)

Who this might be right for
Ovarian Cancer
Ontario Clinical Oncology Group (OCOG) 77
Load More Results